Latest News

Is this dividend star now oversold?

What happened? Shares of credit reporting giant Equifax (NYSE:EFX) fell 2.7% in the afternoon session after RBC Capital analyst Ashish Sabadra downgraded the...

What happened? Shares of telecommunications giant Verizon (NYSE:VZ) fell 3.5% in the afternoon session after the company reported third-quarter revenue below...

What happened? A number of stocks jumped in the afternoon session after U.S. stocks climbed across the board as investors positioned for an eventful week def...

What happened? A number of stocks jumped in the afternoon session after U.S. stocks climbed across the board as investors positioned for an eventful week def...

What happened? Shares of data storage company NetApp (NASDAQ:NTAP) jumped 4% in the afternoon session after Guggenheim analyst Howard Ma initiated coverage o...

What happened? A number of stocks jumped in the afternoon session after Bank of America projected that memory chip supplies would remain tight through 2028 d...

What happened? A number of stocks jumped in the afternoon session after U.S. stocks climbed across the board as investors positioned for an eventful week def...

What happened? A number of stocks jumped in the afternoon session after U.S. stocks climbed across the board as investors positioned for an eventful week def...

Wealth management fees are helping stabilize non-interest revenue, while loan repricing is expanding margins, offsetting mortgage headwinds.

Don't overthink it. These are blue chip stocks that have simply gone on sale and would be solid additions to almost any income portfolio.

OpenText offers a practical way to invest in business AI, with dividend income while the opportunity develops.

Discover the impact of Mark Carney's infrastructure plans on Canada's economy and investment opportunities.

The top cryptocurrency has been a hot buy in recent months.

SoFi is demonstrating fantastic results and has a long growth runway.

Ambev stock plunged after the surprise win for the leftist Lula da Silva in Brazil over the weekend.

Rising delinquencies from government-backed loans mask lower expected losses, a trade-off that tests whether collateral quality can sustain profitability.

Hawaii's insulated deposit market may shield margins while a California acquisition diversifies revenue concentration.

San Francisco's supply crunch is forcing tenants into early renewals, potentially locking in pricing power for years ahead.

Meta Platforms is starting to make real money outside of advertising.

Anthropic is set to go public in a highly anticipated IPO.

Micron's extraordinary profits raise a question investors can't ignore: How much of today's earnings power can survive the next memory cycle?

The S&P 500 is at around record levels, with a lot of exposure to tech.

Tesla is looking to start manufacturing its Optimus robots, but this industrial giant has been helping factories automate for decades.

Xencor (NASDAQ:XNCR) reported updated Phase 1 dose-expansion results for its ENPP3-targeting CD3 T-cell engager, XmAb819, in previously treated advanced clear cell renal cell carcinoma at the ESMO 2026 conference. The company said it selected a 400 microgram-per-kilogram intravenous target dose for